Regulation of vasopressin V1b receptors in the anterior pituitary gland of the rat
- PMID: 10795903
- DOI: 10.1111/j.1469-445x.2000.tb00004.x
Regulation of vasopressin V1b receptors in the anterior pituitary gland of the rat
Abstract
Vasopressin secreted by parvocellular neurones of the hypothalamic paraventricular nucleus modulates pituitary adrenocorticotrophic hormone (ACTH) secretion by acting upon vasopressin V1b type receptors in the pituitary corticotroph coupled to phospholipase C. Regulation of V1b receptors contributes to the adaptation of the hypothalamic-pituitary-adrenal (HPA) axis to stress, as evidenced by the correlation between vasopressin receptor number and pituitary ACTH responsiveness. V1b receptor upregulation during chronic stress is associated with elevated circulating glucocorticoids and vasopressin expression in parvocellular neurones, suggesting that these factors control V1b receptor expression. Removal of circulating glucocorticoids by adrenalectomy causes sustained vasopressin receptor downregulation, but reduces V1b receptor mRNA only transiently. The latter effect is not mediated by increased corticotrophin-releasing hormone (CRH) and vasopressin release, since it is not prevented by lesions of the hypothalamic paraventricular nucleus. Adrenalectomy causes sustained V1b receptor loss in Brattleboro rats, which lack hypothalamic vasopressin, suggesting that vasopressin mediates V1b receptor mRNA recovery. Exogenous glucocorticoid administration downregulates pituitary vasopressin binding but increases V1b receptor mRNA and facilitates coupling of the receptor to phospholipase C, effects which may contribute to the refractoriness of vasopressin actions to glucocorticoid feedback. The lack of parallelism between changes in pituitary vasopressin binding and V1b receptor mRNA levels during manipulation of the HPA axis indicates that V1b receptor content depends on post-transcriptional mechanisms rather than steady-state V1b receptor mRNA levels. These studies suggest that interaction between glucocorticoids and vasopressin plays an important role in regulating V1b receptor mRNA expression during alterations of the HPA axis. In addition, the recent characterization of a major part of the V1b receptor gene provides a basis for studying the molecular mechanisms regulating the V1b receptor.
Similar articles
-
Regulation of pituitary V1b vasopressin receptor messenger ribonucleic acid by adrenalectomy and glucocorticoid administration.Endocrinology. 1997 Dec;138(12):5189-94. doi: 10.1210/endo.138.12.5580. Endocrinology. 1997. PMID: 9389500
-
Glucocorticoids increase vasopressin V1b receptor coupling to phospholipase C.Endocrinology. 1998 Jul;139(7):3220-6. doi: 10.1210/endo.139.7.6121. Endocrinology. 1998. PMID: 9645696
-
Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation.Regul Pept. 2000 Dec 22;96(1-2):23-9. doi: 10.1016/s0167-0115(00)00196-8. Regul Pept. 2000. PMID: 11102648 Review.
-
Regulation of pituitary vasopressin V1b receptor mRNA during stress in the rat.J Neuroendocrinol. 1995 Dec;7(12):903-10. doi: 10.1111/j.1365-2826.1995.tb00734.x. J Neuroendocrinol. 1995. PMID: 8745267
-
Transcriptional and post-transcriptional mechanisms regulating the rat pituitary vasopressin V1b receptor gene.J Mol Endocrinol. 2003 Apr;30(2):99-108. doi: 10.1677/jme.0.0300099. J Mol Endocrinol. 2003. PMID: 12683934 Review.
Cited by
-
Reduced vasopressin receptors activation mediates the anti-depressant effects of fluoxetine and venlafaxine in bulbectomy model of depression.Psychopharmacology (Berl). 2016 Mar;233(6):1077-86. doi: 10.1007/s00213-015-4187-4. Epub 2015 Dec 23. Psychopharmacology (Berl). 2016. PMID: 26700241
-
Influence of hypothalamic IL-6/gp130 receptor signaling on the HPA axis response to chronic stress.Psychoneuroendocrinology. 2013 Jul;38(7):1158-69. doi: 10.1016/j.psyneuen.2012.11.004. Epub 2012 Dec 4. Psychoneuroendocrinology. 2013. PMID: 23218517 Free PMC article.
-
The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress.Dialogues Clin Neurosci. 2006;8(4):383-95. doi: 10.31887/DCNS.2006.8.4/ssmith. Dialogues Clin Neurosci. 2006. PMID: 17290797 Free PMC article. Review.
-
Vasopressin Surrogate Marker Copeptin as a Potential Novel Endocrine Biomarker for Antidepressant Treatment Response in Major Depression: A Pilot Study.Front Psychiatry. 2020 May 20;11:453. doi: 10.3389/fpsyt.2020.00453. eCollection 2020. Front Psychiatry. 2020. PMID: 32508691 Free PMC article.
-
Exaggerated response of a vasopressin-enhanced green fluorescent protein transgene to nociceptive stimulation in the rat.J Neurosci. 2009 Oct 21;29(42):13182-9. doi: 10.1523/JNEUROSCI.2624-09.2009. J Neurosci. 2009. PMID: 19846706 Free PMC article.